You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER

    SBC: Stemsynergy Therapeutic            Topic: 102

    ABSTRACT Colorectal cancerCRCrepresents the fourth most commonly diagnosed cancer withnew cases each yearUnfortunatelyCRC results in a disproportionate number of deathsprojected indue to advanced stage at diagnosisthe aggressive phenotype of the disease and lack of effective therapeuticsGreater thanof CRC patients possess activating mutations in the WNT signaling pathwayWNT pathway activation is a ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  2. Novel IL-15 Superagonist Therapy for Bladder Cancer

    SBC: Altor BioScience, LLC            Topic: NCI

    Project SummaryBladder cancer is the fifth most common cancer in the U SUp toof patients initially present with non muscle invasive bladder cancerNMIBCconfined to the mucosa of the bladderThese patients are treated by tumor resection followed by intravesical chemotherapy or Bacillus Calmette Gu rinBCGtherapyDespite treatmentup toof patients will experience tumor recurrence andof theseaboutwill und ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing.

    SBC: Specific Diagnostics, Inc.            Topic: NIAID

    Project Summary Antibiotic resistance has recently emerged as a global threat for healthcare systemsAn increasing number of pathogenic bacteria are acquiring antibiotic resistanceand new forms of resistance are continuously emerging with alarming speed across international boundariesIn the USalonethe Center for Disease Control and PreventionCDChas estimatedmillion patients per year are directly af ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Combining faster detection with ID: a new paradigm for mycobacterial culture

    SBC: Specific Diagnostics, Inc.            Topic: NIAID

    Project Summary Abstract TuberculosisTBis one of the leading causes of morbidity and mortality from infectious disease worldwide with an estimatedmillion cases of active TB andmillion deaths from the disease annuallyDespite emerging new technologiesculture remains the gold standard in TB diagnosis and therapeutic monitoringInthe World Health OrganizationWHOrecommended the use of a liquid culturing ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  5. IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS

    SBC: IFIT PROSTHETICS, LLC            Topic: N

    ABSTRACT The principal business interestiFIT Prosthetics LLCwith STTR fundingcreated a new transtibial prosthetic device and demonstrated its safetycomfortand functionIn contrast to conventionally made prosthetic limbsthe iFIT prosthesis is easily fit and aligned on the residual limb in a single sessionDue to its substantial adjustability and customized inner linerthe iFIT device is a comfortable ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  6. WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION?

    SBC: EMMUNE INC            Topic: r

    DESCRIPTIONprovided by applicantWe have engineered a synthetic antibody that neutralizesof HIV strainsThis antibody is built from the parts of CDand CCRthat are recognized by HIVand is named "eCDIg " The goal of our research program is now to maximize its efficacyA fundamental question for our effort and for the field as a whole isWhich isotype of IgG has the properties that are most important for ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. Restimulating memory T cell responses in elderly by a novel, live influenza vaccine

    SBC: FLUGEN INC            Topic: NIAID

    Respiratory infections with influenza viruses cause severe morbidity and mortality in humans and animals worldwideImportantlyin humansthe majority of morbidity and mortality following flu infection is seen in older individualsrtyears oldYetclear understanding of how aging impacts on innate immune responsesand how to improve vaccine design in this age group is lackingRestimulating preexisting memor ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomics' reduced genome E. coli strains

    SBC: SCARAB GENOMICS, LLC            Topic: NIAID

    Scarab Genomicsgoal is to commercialize carrier proteins for conjugate vaccine manufactureThis proposal focuses on two bacterial carrier proteins that have been approved by the FDA and that are in use in pre clinical and clinical studiesExoprotein AEPAfrom Pseudomonas aeruginosa and Protein DPDfrom non typeable Haemophilus influenzaeThese proteins are difficult to make by the conventional Ecoli fe ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Complete genome de novo assembly software for the emerging long read sequencing era

    SBC: DNASTAR, INC.            Topic: 400

    Despite the tremendous success of short read next generation sequencingNGStechnologiestheir inherent inability to establish long range connectivity makes fundamental tasks such as genome closurehaplotype phasing and alternatively spliced transcript characterization all but impossibleNowtwo long read sequencing providersPacific BiosciencesPacBioand Oxford Nanopore TechnologiesONTare producing data ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Individualized Signal Processing Strategy:Phase II

    SBC: SECURBORATION, INC.            Topic: NIDCD

    This project describes a novel approach to automate and individualize the signal processing strategy for hearing aidsHAthat can result in improved speech intelligibility in background noisegreater user satisfaction and acceptance for HAsand reduce barriers to affordable hearing health careThe proposed Individualized Signal Processing StrategyISPSis based on individual performance on categorical pe ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government